The Big Picture: PACS vendors vie for piece of software pieBy Kathy Kincade, EditorAs the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development
By Kathy Kincade, Editor
As the healthcare industry finally catches up to the rest of the PC-based world, there is a growing need to create new programming and applications-development environments tailored to the needs of the medical community. Or is there?
With the increasing sophistication of PACS, certain components are becoming commodities. As a result, some vendors have begun searching for new revenue streams. And with the advent of enterprise-wide image distribution, software represents one potentially lucrative niche. This opportunity has drawn the attention of several PACS and modality vendors, which have created software platforms with the hope of attracting new business from both their customers and their competitors.
But is this just another example of trying to reinvent the wheel? A handful of software developers have been adequately serving this market for many years. In addition, the medical imaging community has been quite successful in its cooperative approach to standards development. Look at DICOM and HL7.
And then there is the open architecture of the PC itself, which overcomes the legacy-system problem and offers a number of non-healthcare-specific application-development tools created and refined by computer companies with immense resources and expertise at their disposal. Software is, after all, their business.
But not necessarily software that is specific to the needs of the medical imaging industry. That requires yet another level of expertise from developers who understand how the medical community works and what tools they need to help them do their jobs better.
© 2000 Miller Freeman, Inc., a United News & Media company
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.